Mediastinal lymphadenopathy in patients with severe COVID-19
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Mediastinal lymphadenopathy in patients with severe COVID-19
Subject
Description
CT has a leading place in the management of patients with coronavirus disease 2019 (COVID-19). Mediastinal lymph node enlargement is not considered a typical CT feature of COVID-19, and only 6% of patients admitted to hospital for COVID-19 had lymphadenopathy.
Date
2020-04-21
Type
Citation
Valette, Xavier, Damien du Cheyron, and Suzanne Goursaud. 2020. "Mediastinal lymphadenopathy in patients with severe COVID-19." The Lancet Infectious Diseases.
Accessibility
Free online on Lancet site.
Was this resource helpful?